-
EP4288455
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4288455
| EP4288455 - BINDING AGENTS AND METHODS OF USING THE SAME [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 10.11.2023 Database last updated on 15.06.2024 | |
| Former | The international publication has been made Status updated on 12.08.2022 | ||
| Former | unknown Status updated on 05.03.2022 | Most recent event Tooltip | 05.04.2024 | Change: Validation states | published on 08.05.2024 [2024/19] | 05.04.2024 | Change - extension states | published on 08.05.2024 [2024/19] | Applicant(s) | For all designated states Mozart Therapeutics, Inc. 500 Fairview Avenue, Suite 600 Seattle, Washington 98109 / US | [2023/50] | Inventor(s) | 01 /
CRANE, Courtney Seattle, Washington 98109 / US | 02 /
SWIDEREK, Kristine Seattle, Washington 98109 / US | 03 /
JULIEN, Susan Seattle, Washington 98109 / US | [2023/50] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2023/50] | Application number, filing date | 22705939.1 | 02.02.2022 | [2023/50] | WO2022US14881 | Priority number, date | US202163145394P | 03.02.2021 Original published format: US 202163145394 P | US202163148016P | 10.02.2021 Original published format: US 202163148016 P | US202163161325P | 15.03.2021 Original published format: US 202163161325 P | US202163209949P | 11.06.2021 Original published format: US 202163209949 P | US202263298028P | 10.01.2022 Original published format: US 202263298028 P | [2023/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022169825 | Date: | 11.08.2022 | Language: | EN | [2022/32] | Type: | A1 Application with search report | No.: | EP4288455 | Date: | 13.12.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.08.2022 takes the place of the publication of the European patent application. | [2023/50] | Search report(s) | International search report - published on: | EP | 11.08.2022 | Classification | IPC: | C07K16/28, A61P37/06 | [2023/50] | CPC: |
C07K16/2815 (EP,IL,KR,US);
A61P35/00 (US);
A61P37/06 (EP,IL,KR,US);
C07K16/2803 (EP,IL,KR,US);
A61K2039/505 (KR,US);
C07K2317/31 (EP,IL,KR,US);
C07K2317/526 (EP,IL,KR);
C07K2317/74 (US);
C07K2317/76 (EP,IL,KR,US);
C07K2317/92 (EP,IL,KR,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/50] | Title | German: | BINDEMITTEL UND VERFAHREN ZUR VERWENDUNG DAVON | [2023/50] | English: | BINDING AGENTS AND METHODS OF USING THE SAME | [2023/50] | French: | AGENTS DE LIAISON ET LEURS MÉTHODES D'UTILISATION | [2023/50] | Entry into regional phase | 23.08.2023 | National basic fee paid | 23.08.2023 | Designation fee(s) paid | 23.08.2023 | Examination fee paid | Examination procedure | 23.08.2023 | Examination requested [2023/50] | 23.08.2023 | Date on which the examining division has become responsible | 02.04.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.02.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2012160448 (INNATE PHARMA SA [FR], et al) [A] 1-8,12-14,27-54,60-83,89-113,119-142,148-161 * paragraphs [0025] - [0027] - [0061] , [0 64] , [0 65] , [0 76] - [0078] - [0 80] , [0 81] , [0089] , [0180] , [0594]; examples 1-4; sequences 1,2 *; | [A]WO2014066532 (BRISTOL MYERS SQUIBB CO [US], et al) [A] 1-8,12-14,27-54,60-83,89-113,119-142,148-161 * page 3, line 14 - page 4, line 7 * * page 14, line 1 - page 15, line 13 * * page 17, line 5 - line 10; examples 1-5,8,10,11 *; | [AD]WO2014164553 (IMAGINAB INC [US]) [AD] 1-8,12-14,27-54,60-83,89-113,119-142,148-161 * paragraphs [0001] - [0008] - [0 11] , [0 79] , [ 107] - [0111] - [0114] - [0117] - [0172] , [0193] , [0200]; figures 12D, 12G; examples 4-10, 14-16,20; sequences 42, 48 *; | [I]WO2016196912 (DANA FARBER CANCER INST INC [US]) [I] 1-8,12-14,27-54,60-83,89-113,119-142,148-161 * page 2, line 23 - page 3, line 22 * * page 4, line 3 - line 6 * * page 19, line 31 - page 22, line 13 * * example 11; claims 9-13, 22-26 *; | [A]WO2019032661 (ORIONIS BIOSCIENCES INC [US], et al) [A] 1-8,12-14,27-54,60-83,89-113,119-142,148-161 * page 45, line 14 - line 26 * * page 46, line 25 - page 47, line 16 * * page 48, line 33 - page 49, line 31 * * page 55, line 13 - line 25 * * page 88, line 6 - line 30 * * page 90, line 16 - line 22 *; | [AP]WO2021026233 (UNIV LELAND STANFORD JUNIOR [US]) [AP] 1-8,12-14,27-54,60-83,89-113,119-142,148-161* paragraphs [0009] - [0012] - [0 37] , [0 38]; example 2 *; | [A] - SALIGRAMA NARESHA ET AL, "Opposing T cell responses in experimental autoimmune encephalomyelitis", NATURE, NATURE PUBLISHING GROUP UK, LONDON, vol. 572, no. 7770, doi:10.1038/S41586-019-1467-X, ISSN 0028-0836, (20190807), pages 481 - 487, (20190807), XP036867488 [A] 1-8,12-14,27-54,60-83,89-113,119-142,148-161 * the whole document, in particular page 484, right-hand column, 2nd paragraph - page 485, left-hand column, first paragraph and figure 6 * DOI: http://dx.doi.org/10.1038/s41586-019-1467-x | [A] - PENDE DANIELA, "Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation", FRONT. IMMUNOL., (20190528), vol. 10, no. Article 1179, doi:https://doi.org/10.3389/fimmu.2019.01179, pages 1 - 18, XP055918423 [A] 1-8,12-14,27-54,60-83,89-113,119-142,148-161 * the whole document * DOI: http://dx.doi.org/https://doi.org/10.3389/fimmu.2019.01179 | [A] - LOURDES GIMENO ET AL, "KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling", CANCERS, (20201015), vol. 12, doi:10.3390/cancers12102991, pages 1 - 20, XP055918429 [A] 1-8,12-14,27-54,60-83,89-113,119-142,148-161 * the whole document, in particular page 3, second paragraph * DOI: http://dx.doi.org/ | [AP] - MISHRA SHRUTI ET AL, "CD8+ Regulatory T Cell - A Mystery to Be Revealed", FRONT. IMMUNOL., (20211018), vol. 12, no. Article 708874, doi:https://doi.org/10.3389/fimmu.2021.708874, pages 1 - 7, XP055918437 [AP] 1-8,12-14,27-54,60-83,89-113,119-142,148-161 * the whole document, in particular page 2, left-hand column, second paragraph - right-hand column, last paragraph * DOI: http://dx.doi.org/https://doi.org/10.3389/fimmu.2021.708874 | by applicant | US4518584 | WO8702671 | US4676980 | US4704692 | US4737462 | US4946778 | WO9308829 | US5500362 | US5731168 | US5770387 | US5821337 | US5885573 | US5929212 | WO9951642 | US6080560 | US6194551 | WO0129242 | US2001018041 | US2002168362 | US6512162 | US2003031668 | US2003167531 | US2003232009 | US6737056 | US2004132028 | WO2004056312 | WO2004106381 | WO2005061547 | US2005158305 | WO2005100402 | US2005266001 | WO2006003179 | US2006025576 | WO2006029879 | EP1691833 | US2006270045 | WO2007024715 | WO2007042261 | US7250297 | US2007224633 | US7332581 | WO2008024188 | US2008069820 | WO2008119567 | US2008254027 | WO2009080251 | WO2009080252 | WO2009080253 | WO2009080254 | WO2009089004 | US2009269787 | US2009304710 | US7695936 | US2010092482 | US2010196359 | US2010303828 | US2011171215 | US2011243929 | US2011250203 | US2011250213 | WO2012130831 | WO2013026833 | US2013216540 | US2013236476 | US2013251733 | US2013251711 | US8551478 | US2013273062 | WO2014164553 | US2014308276 | US2014377284 | US2015086574 | US2015232556 | US2015290316 | US2015344580 | US2016053014 | US2016145350 | EP3072522 | US2016304610 | US2016355587 | US2017198050 | WO2017134306 | US2017306016 | US2017313774 | US2018072804 | US2018104308 | WO2018148223 | US2018237529 | US2018256710 | WO2018223004 | US2018355043 | US2018362655 | US2019008955 | US2019048078 | US2019062448 | US2019071500 | US2019071503 | US2019079077 | US2019092868 | US10253095 | US2019119391 | US2019125832 | US2019169283 | US2019256598 | US2019276538 | US2019309069 | US2019322749 | US2019382488 | US2020023045 | US2020071404 | US2020071403 | US2020131272 | US2020148781 | US10668180 | US2020199228 | US2020216548 | US2020247898 | US2020277372 | US2020347144 | US2020399391 | US2020408765 | US2021009706 | US2021009687 | - HUSTON, Sci. U.S.A., (19880000), vol. 85, pages 5879 - 5883 | - JOHNSTON et al., Science, (19880000), vol. 242, pages 1038 - 1041 | - HOLLIGER, R et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 64446448 - 6448 | - POLJAK, R. J, Structure, (19940000), vol. 2, pages 1121 - 1123 | - MILSTEINCUELLO, Nature, (19830000), vol. 305, page 537 | - TRAUNECKER et al., EMBO J., (19910000), vol. 10, page 3655 | - BRENNAN et al., Science, (19850000), vol. 229, page 81 | - KOSTELNY et al., J. Immunol., (19920000), vol. 148, no. 5, pages 1547 - 1553 | - GRUBER et al., J. Immunol., (19940000), vol. 152, page 5368 | - TUTT et al., J. Immunol., (19910000), vol. 147, page 60 | - BOSTROM et al., Science, (20090000), vol. 323, pages 1610 - 14 | - RIDGWAY et al., Prot Eng, (19960000), vol. 9, pages 617 - 621 | - CARTER, J Immunol Meth, (20010000), vol. 248, pages 7 - 15 | - CARTER, J Immunol Methods, (20010000), vol. 248, pages 7 - 15 | - HOUSTON, J. S., Methods in Enzymol., (19910000), vol. 203, pages 46 - 96 | - RAAGWHITLOW, FASEB, (19950000), vol. 9, pages 73 - 80 | - BIRDWALKER, TIBTECH, (19910000), vol. 9, pages 132 - 137 | - SOKOLOWSKA-WEDZINA et al., Mol. Cancer Res., (20170000), vol. 15, no. 8, pages 1040 - 1050 | - HASLER et al., Mol. Immunol., (20160000), vol. 75, pages 28 - 37 | - COSSINS et al., Prot Express Purif, (20060000), vol. 51, pages 253 - 259 | - LI et al., Immunol., (20170000), vol. 188, pages 89 - 95 | - MUYLDERMANS et al., TIBS, (20010000), vol. 26, pages 230 - 235 | - YAU et al., J Immunol Methods, (20030000), vol. 281, pages 161 - 75 | - MAASS et al., J Immunol Methods, (20070000), vol. 324, pages 13 - 25 | - BRINKMANNKONTERMANN, MAbs, (20170000), vol. 9, no. 2, pages 182 - 212 | - WANG et al., Antibodies, (20190000), vol. 8, page 28 | - DONG et al., MAbs, (20110000), vol. 3, pages 273 - 88 | - NATSUME et al., J. Biochem., (20060000), vol. 140, no. 3, pages 359 - 368 | - CHEAL et al., Mol. Cancer Ther., (20140000), vol. 13, no. 7, pages 1803 - 1812 | - WU et al., Nat Biotechnol, (20070000), vol. 25, pages 1290 - 97 | - CHELIUS et al., MAbs, (20100000), vol. 2, no. 3, pages 309 - 319 | - KONTERMANN et al., Drug Discovery Today, (20150000), vol. 20, no. 7, pages 838 - 847 | - GEBAUERSKERRA, "Engineered protein scaffolds as next-generation antibody therapeutics", Curr Opin Chem Biol, (20090000), vol. 13, pages 245 - 255 | - STUMPP et al., "Darpins: A new generation of protein therapeutics", Drug Discovery Today, (20080000), vol. 13, doi:10.1016/j.drudis.2008.04.013, pages 695 - 701, XP023440383 DOI: http://dx.doi.org/10.1016/j.drudis.2008.04.013 | - Biochim Biophys Acta, (20000000), vol. 1482, pages 337 - 350 | - J. Mol. Biol., (20030000), vol. 332, pages 489 - 503 | - PNAS, (20030000), vol. 100, no. 4, pages 1700 - 1705 | - J. Mol. Biol., (20070000), vol. 369, pages 1015 - 1028 | - RAVETCHKINET, Annu. Rev. Immunol., (19910000), vol. 9, pages 457 - 492 | - HELLSTROM, I. et al., Proc. Nat'l Acad. Sci. USA, (19860000), vol. 83, pages 7059 - 7063 | - HELLSTROM, I et al., Proc. Nat'l Acad. Sci. USA, (19850000), vol. 82, pages 1499 - 1502 | - BRUGGEMANN, M. et al., J. Exp. Med., (19870000), vol. 166, pages 1351 - 1361 | - CLYNES et al., Proc. Nat'l Acad. Sci. USA, (19980000), vol. 95, pages 652 - 656 | - GAZZANO-SANTORO et al., J. Immunol. Methods, (19960000), vol. 202, page 163 | - CRAGG, M. S. et al., Blood, (20030000), vol. 101, pages 1045 - 1052 | - CRAGG, M. S.M. J. GLENNIE, Blood, (20040000), vol. 103, pages 2738 - 2743 | - SHIELDS et al., J. Biol. Chem., (20010000), vol. 9, no. 2, pages 6591 - 6604 | - IDUSOGIE et al., J. Immunol., (20000000), vol. 164, pages 4178 - 4184 | - A. L. LEHNINGER, Biochemistry, Worth Publishers, (19750000), pages 73 - 75 | - WALDER et al., Gene, (19860000), vol. 42, page 133 | - BAUER et al., Gene, (19850000), vol. 37, page 73 | - CRAIK, BioTechniques, (19850100), pages 12 - 19 | - LOHWASSER et al., International Immunology, (20010000), vol. 13, pages 321 - 327 | - SARANTOPOULOS et al., J. Clin. Invest., (20040000), vol. 114, no. 9, pages 1218 - 1221 | - GORMAN et al., PNAS, (19820000), vol. 79, page 6777 | - WEIDLE et al., Gene, (19870000), vol. 51, page 21 | - SABIN et al., Bio/Technol., (19890000), vol. 7, page 705 | - MILLER et al., Bio/Technol, (19890000), vol. 7, page 698 | - OKAYAMA et al., Mol. Cell. Biol., (19830000), vol. 3, page 280 | - GROSSCHEDL et al., Cell, (19850000), vol. 41, page 885 | - DNA Cloning, IRL Press, (19850000), vol. 45 | - SITARAMAN et al., Methods Mol. Biol., (20090000), vol. 498, pages 229 - 44 | - SPIRIN, Trends Biotechnol., (20040000), vol. 22, pages 538 - 45 | - ENDO et al., Biotechnol. Adv., (20030000), vol. 21, pages 695 - 713 | - HUSTON et al., Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, pages 5879 - 5883 | - WARD et al., Nature, (19890000), vol. 334, pages 544 - 54 | - Immunol. Meth., Acad. Press, (19790000), vol. I & II | - SALIGRAMA et al., Nature, (20190000), vol. 572, pages 481 - 487 |